Nostrum Pharmaceuticals LLC v. FDA

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• stating that “our review [under Section 505(h)] is limited to final rejections of drug applications, not interim decisions or nonbinding statements subject to further [agency] review or change”

Source: CourtListener parenthetical corpus (CC0).